CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 161 filers reported holding CASTLE BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,500,226 | +385.6% | 148,030 | +294.4% | 0.02% | +375.0% |
| Q2 2023 | $514,910 | -12.0% | 37,530 | +45.8% | 0.00% | -33.3% |
| Q1 2023 | $584,903 | -56.8% | 25,744 | -55.2% | 0.01% | -45.5% |
| Q4 2022 | $1,352,585 | -68.8% | 57,459 | -65.5% | 0.01% | -69.4% |
| Q3 2022 | $4,339,000 | +17.8% | 166,394 | -0.8% | 0.04% | 0.0% |
| Q2 2022 | $3,684,000 | +33.1% | 167,763 | +171.9% | 0.04% | +44.0% |
| Q1 2022 | $2,768,000 | +57.0% | 61,704 | +50.1% | 0.02% | +56.2% |
| Q4 2021 | $1,763,000 | -42.6% | 41,114 | -10.9% | 0.02% | -50.0% |
| Q3 2021 | $3,069,000 | +52.7% | 46,136 | +68.3% | 0.03% | +52.4% |
| Q2 2021 | $2,010,000 | +6.6% | 27,413 | -0.4% | 0.02% | -8.7% |
| Q1 2021 | $1,886,000 | +250.6% | 27,531 | +244.1% | 0.02% | +228.6% |
| Q4 2020 | $538,000 | -86.7% | 8,000 | -89.8% | 0.01% | -90.9% |
| Q3 2020 | $4,050,000 | +246.7% | 78,700 | +153.9% | 0.08% | +381.2% |
| Q2 2020 | $1,168,000 | – | 31,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |